Efficacy and safety of apatinib as second or later-line therapy in extensive-stage small cell lung cancer: a prospective, exploratory, single-arm, multi-center clinical trial

por Liu, Quan, Xu, Juan-Ying, Xu, Ye-Hong, Chen, Meng, Deng, Li-Chun, Wu, Jian-Ping, Zhou, Tong, Zhang, Li-Qin, Tan, Jie, Pu, Xing-Xiang, Shang, Yu-Long, Hua, Jun, Li, Yuan-Qin, Cai, Wei, Gu, Yu-Lan, Peng, Xing-Chen, Chan, Po-Chung, Jabbour, Salma K., Nam, Hae-Seong, Hua, Dong
Publicado 2022